The Self-administered Drugs Market is emerging as a cornerstone of modern, patient-centric healthcare, enabling individuals to manage chronic and acute conditions without frequent clinical visits. Driven by advances in drug delivery technologies, growing preference for home-based care, and rising chronic disease prevalence, the market reached a valuation of US$ 88,514.6 million in 2024. It is...